Cart
sales@molnova.com
L-Carnitine hydrochloride
CAS No. 10017-44-4
L-Carnitine hydrochloride( —— )
Catalog No. M10022 CAS No. 10017-44-4
It is used therapeutically to stimulate gastric and pancreatic secretions and in the treatment of hyperlipoproteinemias.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 34 | In Stock |
|
| 10MG | 45 | In Stock |
|
| 25MG | 61 | In Stock |
|
| 50MG | 98 | In Stock |
|
| 100MG | 129 | In Stock |
|
| 200MG | 181 | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameL-Carnitine hydrochloride
-
NoteResearch use only, not for human use.
-
Brief DescriptionIt is used therapeutically to stimulate gastric and pancreatic secretions and in the treatment of hyperlipoproteinemias.
-
DescriptionConstituent of striated muscle and liver. It is used therapeutically to stimulate gastric and pancreatic secretions and in the treatment of hyperlipoproteinemias. (In Vitro):When expressed in human embryonic kidney (HEK)293 cells, hOCTN2 (SLC22A5) shows low but significant stereospecific transport activity: D-carnitine is transported with lower affinity (Km=10.9 μM) than the L-isomer (Km=4.3 μM).
-
In VitroWhen expressed in human embryonic kidney (HEK)293 cells, hOCTN2 (SLC22A5) shows low but significant stereospecific transport activity: D-carnitine is transported with lower affinity (Km=10.9 μM) than the L-isomer (Km=4.3 μM).
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorCRAT
-
Research AreaOther Indications
-
Indication——
Chemical Information
-
CAS Number10017-44-4
-
Formula Weight197.66
-
Molecular FormulaC7H15NO3·HCl
-
Purity>98% (HPLC)
-
SolubilityDMSO: > 10 mM
-
SMILESC[N+](C)(C)C[C@H](CC(=O)O)O.[Cl-]
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Merra G, et al. World J Gastroenterol. 2012 Sep 28;18(36):5065-7
molnova catalog
related products
-
Kemptide
Kemptide is a synthetic heptapeptide, acting as a substrate for cAMP-dependent protein kinase (PK).
-
Frovocimab
Frovocimab (LY 3015014) is a humanized IgG4 monoclonal antibody to Subtilisin/Kexin Protein Converting Enzyme Type 9 (PCSK9) that binds to the catalytic domain of PCSK9 and lowers low-density lipoprotein cholesterol (LDL-C) in patients with hypercholesterolemia.Frovocimab is used in the study of hypercholesterolemia.
-
threo-Guaiacylglycer...
the absolute configurations of guaiacylglycerol-β-coniferyl aldehyde ether had an impact on the inhibitory effect on Hep3B cells.
